- Home
- ELVN vs TGLS Comparison
ELVN vs TGLS Comparison
Compare ELVN & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | TGLS |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ELVN | TGLS |
|---|---|---|
| Price | $41.49 | $41.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $43.40 | ★ $63.33 |
| AVG Volume (30 Days) | ★ 925.8K | 263.2K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 3.42 |
| Revenue | N/A | ★ $370,984,000.00 |
| Revenue This Year | N/A | $13.56 |
| Revenue Next Year | N/A | $9.04 |
| P/E Ratio | ★ N/A | $12.07 |
| Revenue Growth | N/A | ★ 17.98 |
| 52 Week Low | $14.79 | $39.53 |
| 52 Week High | $48.53 | $90.34 |
Technical Indicators
Market Signals| Indicator | ELVN | TGLS |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 38.06 |
| Support Level | $16.84 | $40.35 |
| Resistance Level | $48.53 | $46.82 |
| Average True Range (ATR) | 2.29 | 1.52 |
| MACD | -0.97 | -0.28 |
| Stochastic Oscillator | 17.12 | 6.48 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About TGLS Tecnoglass Inc.
Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.